Document is current
Any future updates will be listed below
-
Authors
St. Laurent, Jessica D.
Xu, Grace D. https://orcid.org/0009-0005-1894-0089
Ying, Alexander W.
Gokbayrak, Bengul https://orcid.org/0000-0003-0504-6078
Patil, Ajinkya
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Cervantes, Kasey S.
Chen, Shary
Feng, William W. https://orcid.org/0000-0002-8976-5020
Sankar, Akshay
Samé Guerra, Daniel D.
Qi, Jun https://orcid.org/0000-0002-1461-3356
Neel, Dana S.
Hornick, Jason L. https://orcid.org/0000-0001-6475-8345
Kolin, David L. https://orcid.org/0000-0002-7631-6525
Gygi, Steven P. https://orcid.org/0000-0001-7626-0034
Hunstman, David G.
Wang, Yemin https://orcid.org/0000-0002-2970-9510
Kadoch, Cigall https://orcid.org/0000-0002-4058-5985
-
Funding
Funding for this research was provided by:
Howard Hughes Medical Institute (Investigator)
U.S. Department of Health & Human Services | National Institutes of Health (K12-HD000849-37)
Terry Fox Research Institute (1082, 1116)
- License Information
-
More Information
Article History
Received: 20 August 2024
Accepted: 13 August 2025
First Online: 20 October 2025
Competing interests
: C.K. is the Scientific Founder, Scientific Advisor to the Board of Directors, Scientific Advisory Board member, shareholder and consultant for Foghorn Therapeutics, Inc., serves on the Scientific Advisory Board of Nereid Therapeutics and is a consultant for Google Ventures. C.K. is also a member of the Molecular Cell and Cell Chemical Biology editorial boards. J.S.L is a shareholder for AI Proteins Inc. The other authors declare no competing interests.
